Clinical Trial Update: Phase 2 Study of RSLV-132 in Subjects With Long COVID [Phase 2]

View source ↗

Summary

Phase 2 study of RSLV-132 in subjects with Long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• RSLV-132

Snippet

Sponsor: Resolve Therapeutics | Conditions: Post-acute Corona Virus 19 (COVID-19) (Long COVID) | Phase 2 | Status: COMPLETED